Segment and Geographic Information |
14.
|
Segment and Geographic Information
|
The
Company has one reportable operating segment, the results of which
are disclosed in the accompanying unaudited condensed consolidated
financial statements.
Product
revenue by product group is as follows:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2012
|
|
|
2011
|
|
|
2012
|
|
|
2011
|
|
Orthobiologics
|
|
$ |
9,242,783 |
|
|
$ |
10,377,222 |
|
|
$ |
30,262,991 |
|
|
$ |
28,177,115 |
|
Dermal
|
|
|
376,251 |
|
|
|
947,122 |
|
|
|
1,033,302 |
|
|
|
2,335,881 |
|
Ophthalmic
|
|
|
1,891,433 |
|
|
|
4,562,574 |
|
|
|
8,515,160 |
|
|
|
8,045,203 |
|
Surgical
|
|
|
1,426,273 |
|
|
|
1,068,522 |
|
|
|
3,874,405 |
|
|
|
3,748,277 |
|
Veterinary
|
|
|
1,118,700 |
|
|
|
800,560 |
|
|
|
2,865,187 |
|
|
|
1,924,364 |
|
|
|
$ |
14,055,440 |
|
|
$ |
17,756,000 |
|
|
$ |
46,551,045 |
|
|
$ |
44,230,840 |
|
Product
revenue by geographic location in total and as a percentage of
total product revenue, for the three and nine months ended
September 30, 2012 and 2011 are as follows (Prior period numbers
have been reclassified to conform to the current period
presentaion):
|
|
Three Months Ended September 30,
|
|
|
|
2012
|
|
|
2011
|
|
|
|
|
|
|
Percentage of
|
|
|
|
|
|
Percentage of
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
Geographic Location:
|
|
|
|
|
|
|
|
|
|
|
|
|
United
States
|
|
$ |
11,911,946 |
|
|
|
85 |
% |
|
$ |
13,233,998 |
|
|
|
75 |
% |
Europe
|
|
|
1,069,661 |
|
|
|
7 |
% |
|
|
2,512,690 |
|
|
|
14 |
% |
Other
|
|
|
1,073,833 |
|
|
|
8 |
% |
|
|
2,009,312 |
|
|
|
11 |
% |
Total
|
|
$ |
14,055,440 |
|
|
|
100 |
% |
|
$ |
17,756,000 |
|
|
|
100 |
% |
|
|
Nine Months Ended September 30,
|
|
|
|
2012
|
|
|
2011
|
|
|
|
|
|
|
Percentage of
|
|
|
|
|
|
Percentage of
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
Geographic Location:
|
|
|
|
|
|
|
|
|
|
|
|
|
United
States
|
|
$ |
38,317,667 |
|
|
|
82 |
% |
|
$ |
33,170,393 |
|
|
|
75 |
% |
Europe
|
|
|
3,937,427 |
|
|
|
9 |
% |
|
|
6,887,323 |
|
|
|
16 |
% |
Other
|
|
|
4,295,951 |
|
|
|
9 |
% |
|
|
4,173,124 |
|
|
|
9 |
% |
Total
|
|
$ |
46,551,045 |
|
|
|
100 |
% |
|
$ |
44,230,840 |
|
|
|
100 |
% |
|